SG Americas Securities
OLMA icon

SG Americas Securities’s Olema Pharmaceuticals OLMA Stock Holding History

SG Americas Securities’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-69,382
Closed -$1.74M – 3573
2025
Q4 		$1.74M Buy
+69,382
New +$1.23M ﹤0.01% 1620
2025
Q2 		– Sell
-14,193
Closed -$53K – 3404
2025
Q1 		$53K Sell
14,193
-3,282
-19% -$16.5K ﹤0.01% 3235
2024
Q4 		$102K Buy
17,475
+4,419
+34% +$44.1K ﹤0.01% 2728
2024
Q3 		$156K Buy
+13,056
New +$167K ﹤0.01% 2691
2024
Q1 		– Sell
-15,874
Closed -$223K – 3295
2023
Q4 		$223K Buy
15,874
+4,379
+38% +$58.8K ﹤0.01% 2060
2023
Q3 		$142K Buy
+11,495
New +$117K ﹤0.01% 2545
2021
Q4 		– Sell
-14,060
Closed -$387K – 3688
2021
Q3 		$387K Buy
+14,060
New +$380K ﹤0.01% 2723
2021
Q1 		– Sell
-12,300
Closed -$591K – 3483
2020
Q4 		$591K Buy
+12,300
New +$577K ﹤0.01% 1860

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

SG Americas Securities's OLMA Position: Q1 2026 in Review

SG Americas Securities sold out of Olema Pharmaceuticals (OLMA) in Q1 2026, closing a stake of 69,382 shares — an estimated $1.74M sold.

SG Americas Securities first reported a position in OLMA in Q4 2020 and held it in 8 quarters. The position peaked at $1.74M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • SG Americas Securities reported no remaining Olema Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 69,382 Olema Pharmaceuticals shares in Q1 2026, an estimated $1.74M.
  • SG Americas Securities first reported a position in Olema Pharmaceuticals in Q4 2020 and held it in 8 quarters.
  • SG Americas Securities's Olema Pharmaceuticals position peaked at $1.74M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.